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In recent years, life expectancy has increased in many societies consequent to better health conditions. Although the trends of decreasing mortality rates from ischemic heart disease and stroke have continued into the 21st century, both causes continue to be the biggest killers in the Western societies. No change is predicted in the foreseeable future and consequently both these conditions contribute significantly to the burden of disease. 1 Diabetes is considered a cardiovascular disease equivalent and with diabetes patients share the benefits of the improved approach to the treatment of cardiovascular disease. However, because of the longer life span and disease duration, other chronic complications such as peripheral arterial disease (PAD) may well become more evident.
In a recent survey, PAD was present in 21% of newly diagnosed type 2 diabetic patients 2 and in about 50% of the patients admitted to a diabetic foot clinic on account of a new foot ulcer. It is interesting to emphasize that half of those patients had concomitant peripheral neuropathy. 3 Neuropathy can mask the classic PAD symptoms as claudication, thereby delaying a diagnosis. On the other hand, the presence of PAD may limit the use of total contact cast that is considered the "gold standard" treatment for neuropathic ulcerations.
PAD alone is responsible for the increased risk of lower limb amputation observed in patients with diabetes. 4, 5 In type 1 diabetes, the overall 25-year cumulative incidence of lower extremity amputation (LEA) is 10.1%. History of heavy smoking, high HbA1c, presence of hypertension are all factors related to PAD and major determinants associated with LEA. 6 In addition, major complex gender differences exist in diabetes-related LEA: Men are more likely to undergo LEA. 7 The presence of a foot infection increases the risk of LEA.
A multidisciplinary approach to diabetic foot problems is mandatory to reduce the frequency of LEA, particularly when PAD is complicated by the presence of infected foot ulcers. 8 Today significantly better outcomes are expected for patients with diabetes affected by critical limb ischemia (CLI) based on improved technical options in peripheral revascularization, new options in antibiotic therapy, and aggressive wound debridement and wound care. Until recently, open peripheral arterial bypass has been the firstline surgical treatment option for PAD. Although open bypass is associated with successful results, the invasive nature of the surgery can limit optimal overall outcome. Endovascular procedure is less invasive; however, it reaches similar limb salvage rates in patients with CLI, 9 with the added benefits of fewer wound complications and a shorter hospital stay. As expected, endovascular therapy is increasingly being considered as a first-line treatment option in carefully selected PAD diabetic patients. With the widespread adoption of endovascular therapy, there has been a profound shift in practice patterns for lower extremity PAD.
In the past decade, there has been a consistent increase in the number of patients treated by peripheral transluminal angioplasty because of CLI. 10 Hong et al 10 reported that in the general population the average annual number of endovascular interventions is increased by 78% while there is a concomitant decrease in open bypass by 20%. The same authors found that the trends in amputation were consistent with the increase in endovascular therapy. The number of major amputations (ankle to above-the-knee level) decreased by 21% and the number of minor amputations, defined as involving the toe and forefoot, showed a moderate decrease of 5%. Although better outcomes for CLI have been observed in the general population, the LEA observed in patients with diabetes are reportedly reduced, unchanged, or even increased.
A recent survey conducted in England reported that the number and incidence of amputations decreased in the aging nondiabetic population whereas the overall population burden of amputations increased in people with diabetes. 11 In another study, major and minor amputation rates were stable across England between 2003 and 2008, accompanied by a significant reduction in perioperative mortality. 12 Other authors have reported that there was significant reduction in the incidence of major LEA in patients with diabetes over a 7-year period (January 1, 2000 to December 31, 2006). 13 Differences in outcomes have been recorded between patients with PAD versus patients with diabetes and PAD. In addition, the diabetic population showed significant differences in outcomes, that is, neuroischemic foot ulcers fail to heal even after successful arterial revascularization. 14 These differences in outcomes permit some speculations.
First of all, patients with diabetes do not share with the general population the general improvements in outcomes because there are differences in PAD itself. It is possible that the diffuse and distal arterial disease with multiple stenoses/obstructions that are characteristic of PAD in diabetes needs a more aggressive and experienced treatment approach. Such an approach should be revascularization, including all infrapopliteal and pedal arteries, plus the plantar arch. [15] [16] [17] [18] Second, not all the differences can be laid on the door of revascularization techniques.
Some observations report better outcomes for diabetic patients related to a better care of the diabetic foot in general. 19 The importance of a multidisciplinary team approach comes from another study, which showed that visiting a podiatrist as well as a lower extremity clinician specialist in the year before lower extremity complications offered protection against LEA. 20 The importance of a comprehensive foot care emerges from the studies on African Americans. African Americans were found to have 2.4 times greater risk of amputation compared with Caucasians. 10 However, improved outcomes were also recently reported for the African Americans with diabetes as a consequence of community action plans and interventions such as the Racial and Ethnic Approaches to Community Health (REACH) Charleston and the Georgetown Diabetes Coalition. 21 The role of a multidisciplinary clinical approach to the management of diabetic foot ulcers is also evident from our data that report the outcomes of diabetic patients with CLI and foot ulceration and/or gangrene. 22 The author's group uses a comprehensive protocol that includes strong and long-lasting antibiotic therapy, aggressive wound debridement, with an early removal of all the ischemic/infected tissues, a very well-addressed wound care, and extensive distal revascularization. Peripheral transluminal angioplasty has been first-choice technique for distal revascularization in our protocol.
Our comprehensive approach is based on experience derived from 500 diabetic patients with CLI and deep, infected, lower extremity wounds; these carried high risk of major amputation (Class D stage 3 Texas wound classification). These patients were followed up for 5 years. The author found an overall limb salvage in 70% of the patients. This study confirmed that ulcer size is a risk factor for nonhealing and for major amputation. This observation supports the logic that larger ulcers are associated with a larger amputation rate.
Lesions resulting from PAD start small; larger lesions are the consequence of prolonged ineffective treatments. This observation suggests the need for a ready and aggressive approach, also when a small and nonhealing foot ulcer is the only sign of the presence of PAD. Although debatable, a general improvement in the outcomes of diabetic patients with PAD has been achieved though this does not include PAD diabetic patients affected by renal insufficiency. In a study that evaluated mortality after lower limb amputation in patients with diabetes, those with chronic kidney disease and dialysis had more below-knee amputations and aboveknee amputations than patients with no renal disease. In addition, they had reduced survival. 23 In the author's experience, the limb salvage rate of PAD diabetic patients with chronic kidney disease and dialysis is significantly reduced in comparison with that obtained in diabetic patients without kidney disease 24 ; however, the 50% limb salvage rate for those patients is promising, suggesting the need for other studies to further improve the clinical outcomes in these patients.
